Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Valenti

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2026
Corrigendum to "Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells" [Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 1832(12) (2013) 2085-2096]Daniela Valenti, Lidia de Bari, Gabriella Arcangela Manente, et al.
Biochimica Et Biophysica Acta|March 12, 2016
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse modelDaniela Valenti, Lidia de Bari, Domenico de Rasmo, et al.
BMC Infectious Diseases|March 18, 2017
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patientsFranco Maggiolo, Roberto Gulminetti, Layla Pagnucco, et al.
Journal of the International AIDS Society|November 15, 2014
Long-term effect of a four-drugs induction regimen for patients with high baseline viral loadFranco Maggiolo, Giulia Masini, Noemi Astuti, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile menMario Salmeri, Daniela Valenti, Sandro La Vignera, et al.
Neuropharmacology|April 19, 2017
Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndromeDaniela Valenti, Lidia de Bari, Daniele Vigli, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F<sub>0</sub>F<sub>1</sub>-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and EfficacyIris Scala, Daniela Valenti, Valentina Scotto D'Aniello, et al.
Journal of the International AIDS Society|November 15, 2014
Early clinical response and presence of viral resistant minority variants: a proof of concept studyAnnapaola Callegaro, Elisa Di Filippo, Noemi Astuti, et al.
Biological Chemistry|November 9, 2019
Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndromeSimona D'Antoni, Lidia de Bari, Daniela Valenti, et al.
Biochimica Et Biophysica Acta|January 8, 2013
Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndromeDaniela Valenti, Domenico De Rasmo, Anna Signorile, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2026
Corrigendum to "Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells" [Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 1832(12) (2013) 2085-2096]Daniela Valenti, Lidia de Bari, Gabriella Arcangela Manente, et al.
Biochimica Et Biophysica Acta|March 12, 2016
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse modelDaniela Valenti, Lidia de Bari, Domenico de Rasmo, et al.
BMC Infectious Diseases|March 18, 2017
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patientsFranco Maggiolo, Roberto Gulminetti, Layla Pagnucco, et al.
Journal of the International AIDS Society|November 15, 2014
Long-term effect of a four-drugs induction regimen for patients with high baseline viral loadFranco Maggiolo, Giulia Masini, Noemi Astuti, et al.
Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile menMario Salmeri, Daniela Valenti, Sandro La Vignera, et al.
Neuropharmacology|April 19, 2017
Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndromeDaniela Valenti, Lidia de Bari, Daniele Vigli, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F<sub>0</sub>F<sub>1</sub>-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and EfficacyIris Scala, Daniela Valenti, Valentina Scotto D'Aniello, et al.
Journal of the International AIDS Society|November 15, 2014
Early clinical response and presence of viral resistant minority variants: a proof of concept studyAnnapaola Callegaro, Elisa Di Filippo, Noemi Astuti, et al.
Biological Chemistry|November 9, 2019
Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndromeSimona D'Antoni, Lidia de Bari, Daniela Valenti, et al.
Biochimica Et Biophysica Acta|January 8, 2013
Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndromeDaniela Valenti, Domenico De Rasmo, Anna Signorile, et al.
Pageof 8